 |
|
 |
 |
 |
Preventing and Controlling Cancer
The Nation's Second Leading
Cause of Death
At A Glance
2008
This document is also available in
Portable Document Format
(PDF–1.1Mb).
Learn more about
PDFs.

“Our work in cancer prevention and control presents an
extraordinary challenge across the continuum—preventing disease onset,
reducing risk factors, advancing early detection and treatment, improving
access to quality care, enhancing the quality of life for cancer survivors,
and eliminating health disparities. By forging effective partnerships with
those in the cancer community and beyond, we are making a real difference in
reducing the burden of cancer and promoting our nation’s health.”
Barbara Bowman, PhD
Acting Director, Division of Cancer Prevention and Control
National Center for Chronic Disease Prevention and Health Promotion, CDC
The Burden of Cancer
Every year, cancer claims the lives of more than half a million
Americans. Cancer is the second leading cause of death in the United States,
exceeded only by heart disease. According to United States Cancer
Statistics: 2004 Incidence and Mortality, which tracks cancer incidence for
about 98% of the U.S. population and mortality for the entire country, more
than 553,000 Americans died of cancer, and over 1.34 million had a diagnosis
of cancer in 2004.
The financial costs of cancer are overwhelming. According to the National
Institutes of Health (NIH), in 2007, cancers will cost the United States an
estimated $219 billion, including $130 billion for lost productivity and $89
billion in direct medical costs.
Racial and Ethnic Differences
Cancer does not affect all races equally. African Americans are more
likely to die of cancer than people of any other racial or ethnic group. In
2004, the age-adjusted death rate per 100,000 people for all types of cancer
combined was 228 for African Americans, 184 for white Americans, 128 for
American Indians/Alaska Natives, 123 for Hispanic Americans, and 111 for
Asians/Pacific Islanders.
Effective Cancer
Prevention Measures
The number of new cancer cases can be reduced, and many cancer deaths can
be prevented. A person’s cancer risk can be significantly reduced by
adopting a healthy lifestyle, avoiding tobacco use, increasing physical
activity, achieving optimal weight, improving nutrition, and avoiding sun
exposure.
Making cancer screening, information, and referral services available and
accessible to all Americans can lower the high rates of cancer and cancer
deaths. Screening tests for breast, cervical, and colorectal cancers
decrease deaths from these diseases by finding them early, often as
treatable precancerous conditions.

[A text
description of this chart is also available.]
CDC’s Leadership in Detecting, Preventing, and Controlling Cancer
CDC is committed to ensuring that all people, especially those at greater
risk for health disparities, will achieve their optimal lifespan with the
best possible quality of health in every stage of life. With agency-wide
health protection goals that support healthy people in healthy places across
all life stages, CDC is setting the agenda to enable people to enjoy a
healthy life by delaying death and the onset of illness and disability by
accelerating improvements in public health.
With fiscal year 2008 funding of $284 million for cancer prevention and
control activities, CDC is a leader in this area. CDC’s Division of Cancer
Prevention and Control (DCPC) works with national organizations, state
health agencies, and other key groups to develop, implement, and promote
effective cancer prevention and control practices.
CDC’s comprehensive and collaborative approach to addressing the nation’s
cancer burden includes the following:
- Monitoring. CDC helps states, territories, and tribes and
tribal organizations collect data on cancer incidence and deaths, cancer
risk factors, and the use of cancer screening tests. Public health
professionals use these data to identify and track cancer trends,
strengthen cancer prevention and control activities, and prioritize use
of resources.
- Conducting research and evaluation. CDC conducts studies and
supports research, often in collaboration with academic partners, to
develop and promote the application
of sound science to reduce the burden of cancer and eliminate health
disparities. This research uses many different areas of expertise (e.g.,
behavioral science, economics, epidemiology, health services, medicine,
and statistics) to address the public health research needs of our
programs, health care providers, people affected by cancer, and the
larger cancer control community.
- Building capacity and partnerships. CDC works with many
partners to translate research into public health programs, practices,
and services. CDC helps states, U.S. territories, and tribes and tribal
organizations apply scientific advances to the development of strong
cancer control programs for the people who most need them.
- Educating. CDC develops communication campaigns and materials
for teaching health professionals, policy makers, the media, and the
public about the importance of cancer prevention and control.
CDC’s Cancer Programs
The National Breast and Cervical Cancer Early Detection Program (NBCCEDP)
provides clinical breast exams, mammograms, pelvic exams, and Pap tests to
women in need, such as those who are uninsured, have low incomes, or have
health insurance that does not pay for screening services. In addition, the
program provides diagnostic follow-up for abnormal screening results and
referrals to treatment if cancer is diagnosed.
In 2008, the NBCCEDP appropriation of $182 million funds all 50 states,
the District of Columbia, 5 U.S. territories, and 12 American Indian/Alaska
Native tribes or tribal groups to provide clinical screening and diagnostic
services to medically underserved women. Since its inception in 1991, the
NBCCEDP has provided more than 7.2 million breast and cervical cancer
screening and diagnostic exams to more than 3 million women.
The National Comprehensive Cancer Control Program (NCCCP) is an
integrated and coordinated approach to reducing cancer incidence, morbidity,
and mortality through prevention, early detection, treatment,
rehabilitation, and palliation. In 2008, the NCCCP appropriation of $16
million funds all 50 states, the District of Columbia, 7 U.S. territories,
and 7 tribes or tribal groups to establish coalitions, assess the burden of
cancer, determine priorities, and develop and implement comprehensive cancer
control (CCC) programs. Since 1998, the number of programs participating in
the NCCCP has grown from 6 to 65, and grantees have released 56 CCC plans.
The National Program of Cancer Registries (NPCR) collects data on
cancer occurrence; the type, extent, and location of cancers; and the type
of initial treatment. In 2008, the NPCR appropriation of $46 million
supports central cancer registries in 45 states, the District of Columbia,
Puerto Rico, and the U.S. Pacific Island jurisdictions. In addition, CDC
collaborates with the National Cancer Institute’s Surveillance,
Epidemiology, and End Results (SEER) Program to publish annual cancer
incidence and death data in the United States Cancer Statistics:
Incidence and Mortality reports.
Ongoing Initiatives
Colorectal cancer prevention and control. CDC and its partners
promote colorectal cancer screening by supporting education and research
programs. CDC is funding a 3-year demonstration program at the community
level to learn how best to implement colorectal cancer screening for
low-income adults. CDC’s multiyear Screen for Life: National
Colorectal Cancer Action Campaign educates Americans about the importance of
regular screening beginning at age 50. Campaign materials include fact
sheets, brochures, posters, and public service announcements (PSAs). In
2007, the campaign created and distributed PSAs featuring actor Jimmy Smits
(in English and Spanish) and journalist Katie Couric.
Prostate cancer control. CDC provides the public, doctors, and
policy makers with information they need to make informed decisions about
the potential risks and benefits of prostate cancer screening and to improve
quality of life after diagnosis. CDC produces three versions of Prostate
Cancer Screening: A Decision Guide—one for all English-speaking men,
another for African American men, and the third in Spanish for Hispanic men.
CDC also developed a slide presentation for primary care physicians called
Screening for Prostate Cancer: Sharing the Decision.
Skin cancer primary prevention and education. CDC conducts
monitoring, research, education and interventions for skin cancer. Based on
the recommendations of the Guidelines for School Programs to Prevent Skin
Cancer, CDC worked with education agencies and CCC partners to pilot
test strategies to reduce skin cancer risks among students in schools in
Colorado, Michigan, and North Carolina. CDC also is working with partners to
assess the prevalence of sunburn and sun-protective behaviors by using
national surveys such as the Youth Risk Behavior Surveillance System and
National Health Interview Survey. CDC currently funds 9 states for skin
cancer activities under its CCC program.
Hematologic cancer. CDC funds efforts to improve awareness and
understanding of the diagnosis and treatment of hematologic cancers, which
are cancers of the blood and bone marrow. These efforts help the public and
people living with hematologic cancers (as well as their friends and
families) get resources to better understand these diseases, receive optimal
treatment, and find community support networks.
Ovarian cancer. CDC works with academic and medical institutions,
state health departments, and advocacy groups to conduct research to improve
early detection and treatment of ovarian cancer. Cancer registries in
Maryland, California, and New York collaborate with the NPCR to evaluate
care and outcomes for patients with ovarian cancer. The NCCCP also funds
ovarian cancer projects in California, Florida, Michigan, New York,
Pennsylvania, Texas, and West Virginia.
Gynecologic cancer. DCPC is working to increase awareness of
gynecologic cancers through a national campaign called Inside Knowledge: Get
the Facts about Gynecologic Cancer. The project is a joint effort between
CDC and the U.S. Department of Health and Human Services’ Office of Women’s
Health. In 2007, CDC convened an expert panel to make recommendations and
created consumer fact sheets on ovarian, cervical, uterine, vaginal, and
vulvar cancers.
Cervical cancer. CDC is working with partners, including the
registries funded by NPCR and SEER, to assess the burden of cancers
associated with the human papillomavirus (HPV), including cervical, vaginal,
vulvar, anal, penile, and oropharyngeal cancers. This project will culminate
in a supplement to the journal Cancer.
Lung cancer. To prevent and control lung cancer, CDC collects data
on diagnoses and deaths in the United States; supports programs in states,
U.S. territories, and tribes and tribal groups to prevent and control
tobacco use and promote a healthy diet; and implements public health
interventions and counter-marketing strategies to reduce smoking.
Cancer survivorship. Because of advances in the detection and
treatment of cancer, more people are living longer after a cancer diagnosis,
and survivors often face a range of health challenges. CDC works with
national, state, and local partners to create and implement successful
strategies to help the millions of people who live with, through, and beyond
cancer. For example, DCPC and the Lance Armstrong Foundation worked together
to develop A National Action Plan for Cancer Survivorship: Advancing Public
Health Strategies.
Future Directions
To help ensure that people are healthy at every stage of life, CDC is
committed to the following actions:
- Collaborating with partners, policy makers, and other individuals
and groups working to ease the burden of cancer in the United States and
abroad.
- Expanding the use of information technology in cancer surveillance,
particularly in cancer registries.
- Improving the cost-effectiveness of the National Breast and Cervical
Cancer Early Detection Program.
- Defining the proper role for managing chronic diseases, including
cancer, during catastrophic disasters.
- Expanding CDC’s role in addressing public health strategies to
increase survivorship in underserved populations and improve end-of-life
support for cancer patients, their family, their friends, and their
caregivers.
- Expand the colorectal cancer screening demonstration project to
include additional states, territories, and tribes as funds become
available.
State
Program in Action: Delaware
Since the early 1990s,
death rates from cancer have fallen across the United States,
including a dramatic decrease in Delaware—from 10% above the
national average during 1994–1998 to 3% above the national average
during 2000–2004. Despite this progress, the state’s disease and
death rates from cancer remain higher than the national average. In
addition, only 1 in 8 residents has health insurance, and the cost
of treating cancer can be devastating for people without insurance.
Many people do not get screening tests because they cannot afford
treatment if cancer is diagnosed. In 2004, Delaware became the first
state to offer free cancer treatment for people who meet eligibility
requirements. Delaware also provides free screenings for breast,
cervical, and colorectal cancer to eligible residents as part of
Screening for Life, a program in the state’s Division of Public
Health. In 2007, the state added early detection and treatment
services for prostate cancer because prostate cancer accounts for
30.2% of all new cancer cases reported in men in Delaware. |
|
For more information or copies of publications
referenced in this document, please contact
Centers for Disease Control and Prevention
National Center for Chronic Disease Prevention and Health Promotion
4770 Buford Highway NE, Mail Stop K–64, Atlanta, GA 30341-3717
Telephone: 800-CDC-INFO (232-4636) • TTY: 888-232-6348
E-mail: cdcinfo@cdc.gov • Web:
http://www.cdc.gov/cancer
|
|
Page last reviewed: February 13, 2008
Page last modified: February 13, 2008
Content source: National Center for
Chronic Disease Prevention and Health Promotion
|
|